UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

May 3, 2011

Date of Report (Date of earliest event reported)

 

 

 

Commission File Number		Exact Name of Registrant as Specified in Its Charter; State of Incorporation; Address of Principal Executive Offices; and Telephone Number		IRS Employer Identification Number
1-16169		EXELON CORPORATION (a Pennsylvania corporation)   10 South Dearborn Street P.O. Box 805379 Chicago, Illinois 60680-5379 (312) 394-7398		23-2990190

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Section 5-Corporate Governance and Management

Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 3, 2011, Exelon Corporation (Exelon) held its annual meeting of shareholders. The final results of voting on each of the matters submitted to a vote of security holders during Exelon’s annual meeting of shareholders:

1. Election of Directors

 

		FOR				AGAINST				ABSTAIN				BROKER NON-VOTE
John A. Canning, Jr.			402,241,565				5,192,923				1,812,533				106,740,945
M. Walter D’Alessio			398,333,850				9,154,065				1,759,106				106,740,945
Nicholas DeBenedictis			394,918,225				12,581,483				1,767,313				106,740,945
Nelson A. Diaz			377,393,933				29,990,956				1,862,132				106,740,945
Sue L. Gin			399,180,593				8,283,015				1,783,413				106,740,945
Rosemarie B. Greco			396,124,697				11,314,169				1,808,155				106,740,945
Paul L. Joskow			403,669,330				3,724,880				1,852,811				106,740,945
Richard W. Mies			403,125,120				4,181,568				1,940,333				106,740,945
John M. Palms			399,861,765				7,529,426				1,855,830				106,740,945
William C. Richardson			401,862,613				5,541,851				1,842,557				106,740,945
Thomas J. Ridge			401,833,485				5,704,520				1,709,016				106,740,945
John W. Rogers, Jr.			397,617,596				9,802,776				1,826,649				106,740,945
John W. Rowe			388,647,964				18,910,533				1,688,524				106,740,945
Stephen D. Steinour			395,282,107				12,149,737				1,815,177				106,740,945
Don Thompson			403,401,939				4,037,436				1,807,646				106,740,945

2. Ratification of PricewaterhouseCoopers LLP as Exelon’s Independent Accountant for 2011

 

FOR				AGAINST				ABSTAIN
	507,823,923				6,082,575				2,081,468

3. The advisory vote on Exelon’s 2011 executive compensation

 

FOR				AGAINST				ABSTAIN				BROKER NON-VOTE
	389,508,395				13,913,885				5,824,741				106,740,945

4. The advisory vote on the frequency of the advisory vote on executive compensation

 

One Year				Two Years				Three Years				ABSTAIN
	318,308,822				2,952,756				84,967,085				3,018,358

* * * * *

This Current Report includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The factors that could cause actual results to differ materially from these forward-looking statements include those discussed herein as well as those discussed in (1) Exelon’s 2010 Annual Report on Form 10-K in (a) ITEM 1A. Risk Factors, (b) ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations and (c) ITEM 8. Financial Statements and Supplementary Data: Note 18; (2) Exelon’s First Quarter 2011

---

Quarterly Report on Form 10-Q in (a) Part II, Other Information, ITEM 1A. Risk Factors, (b) Part 1, Financial Information, ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations and (c) Part I, Financial Information, ITEM 1. Financial Statements: Note 12; and (3) other factors discussed in filings with the Securities and Exchange Commission by Exelon. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this Current Report. Exelon does not undertake any obligation to publicly release any revision to its forward-looking statements to reflect events or circumstances after the date of this Current Report.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

May 5, 2011